New class drug significantly reduces spine fracture risk in postmenopausal women with osteoporosis
Wednesday, June 14, 2017 - 14:52
in Health & Medicine
In postmenopausal women with osteoporosis, 12 months treatment with romosozumab was associated with rapid and large reductions in their risk of a vertebral fracture compared to placebo, research shows.